For Academia

Thank you for visiting Evidentic! We have created a novel solution for researchers using therapeutic monoclonal antibodies in their daily experiments. For the first time researchers and clinicians have access to small quantities of therapeutic monoclonal antibodies. The demand for therapeutic proteins in research has risen since we have started in September 2017. Our core…

Biosimilar Technology

Biosimilars: biologicals made accessible Antibody-based pharmaceuticals are emerging as a treatment of many conditions. Biosimilar are biopharmaceutical with similar structure and function to these proteins, often produced and marketed at lower costs. The development of biosimilars is then essential to bring these pharmaceuticals to a larger section of the population. However, the manufacturing process for…

Biosimilar comparability exercise

The biosimilar comparability exercise is a series of studies characterizing quality attributes of a reference and a biosimilar product. Approval of the biosimilar product by regulatory agencies is based on demonstrating high similarity between reference and biosimilar products. Guidelines for the conducting of biosimilar comparability exercises have been published by the European Medicines Agency (EMA)…

For Biosimilar Developers

Reference products for biosimilar manufacturers Your hassle-free reference medicinal product source for biosimilar analytics To market a biosimilar product, manufacturers need to perform a head-to-head comparison with its original counterpart, the reference medicinal product (RMP). This process, called biosimilar exercise, aims to highlight the variation in the original manufacturing process and the similarity between biosimilars…